Comment to "Recurrent Glioblastoma Treated with Recombinant Poliovirus"

• 作 者: Peng Wang Guang-Zhong Chen
• 机 构: Department of Neurosurgery, Guangdong General Hospital, Institute of Neuroscience, Guangdong Academy
• 出 处: 中华医学杂志（英文版）
• 发表日期: 2018年21期
• 关键词: malignant glioma surgical resection survival time survival rate

The median follow-up of the malignant glioma patients who received surgical resection combined with radiochemotherapy is 16 months.The recurrence of malignant glioma is unavoidable.Although the patient with recurrent glioblastoma has multiple choices of therapy,the 5-year survival rate is still less than 5％,and the average survival time is less than 12 months.[1] Currently,there is no single second-line drug can have survival benefits.